©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 370-383
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Table 1 Direct and indirect clinical effects of cytomegalovirus after liver transplantation
| Direct effects | Indirect effects |
| CMV syndrome | Acute allograft rejection |
| Fever | Chronic allograft rejection |
| Myelosuppression | Vanishing bile duct syndrome |
| Malaise | Chronic ductopenic rejection |
| Tissue-invasive CMV disease1 | Hepatitis C virus recurrence |
| Gastrointestinal disease | Allograft hepatitis, fibrosis |
| (colitis, esophagitis, gastritis, | Allograft failure |
| enteritis) | Opportunistic and other infections |
| Hepatitis | Fungal superinfection |
| Pneumonitis | Nocardiosis |
| CNS disease | Bacterial superinfection |
| Retinitis | Epstein-Barr virus and PTLD |
| Mortality | HHV-6 and HHV-7 infections |
| Vascular thrombosis | |
| New onset diabetes mellitus | |
| Mortality |
- Citation: Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014; 6(6): 370-383
- URL: https://www.wjgnet.com/1948-5182/full/v6/i6/370.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i6.370